Trial Profile
In vivo assessment of the molecular mechanism of inhaled combination of beclomethasone and formoterol on cell differentiation factors and airway remodelling in COPD
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2015
Price :
$35
*
At a glance
- Drugs Beclometasone/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacodynamics
- 08 Jul 2014 New trial record